Collegeville, PA, United States of America

James C Hershey

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Merck Sharp + Dohme Corp.. Active years: 2011.

USPTO Granted Patents = 1 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2011

Loading Chart...
1 patent (USPTO):Explore Patents

Title: James C. Hershey: Innovator in Cardiovascular Treatment

Introduction

James C. Hershey is a notable inventor based in Collegeville, PA (US). He has made significant contributions to the field of medicine, particularly in the area of cardiovascular treatment. His innovative work has led to the development of a patent that addresses critical health issues.

Latest Patents

James C. Hershey holds a patent for "Mineralocorticoid receptor modulators." This invention relates to diphenylmethyl imidazole mineralocorticoid receptor modulators compounds. These compounds have a specific structure and are utilized in treating cardiovascular events. His patent represents a significant advancement in therapeutic options for patients suffering from cardiovascular conditions.

Career Highlights

Hershey is associated with Merck Sharp & Dohme Corp., a leading pharmaceutical company. His work at Merck has allowed him to collaborate with other talented professionals in the field. His dedication to research and innovation has positioned him as a key figure in the development of new medical treatments.

Collaborations

James C. Hershey has worked alongside esteemed colleagues such as Philip E. Brandish and Mark E. Fraley. These collaborations have fostered an environment of innovation and have contributed to the success of their projects.

Conclusion

James C. Hershey's contributions to the field of cardiovascular treatment through his patent and work at Merck Sharp & Dohme Corp. highlight his role as an influential inventor. His dedication to improving patient outcomes through innovative solutions is commendable.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…